Skip to main content
SpringerLink
Log in
Book cover

Intravesikale Chemotherapie und transurethrale Verfahren zur Behandlung und Rezidivprophylaxe des Blasenkarzinoms pp 3–11Cite as

Prognostische Parameter des Harnblasenkarzinoms

  • Conference paper

Part of the book series: Fortschritte der Urologie und Nephrologie ((2824,volume 19))

Zusammenfassung

Anhand des Krankengutes der Urologischen Klinik und Poliklinik der Universität Mainz von 1968 bis 1972 wurden prognostische Parameter erarbeitet, die im folgenden mit einer kurzen Literaturübersicht der letzten Jahre vorgestellt werden sollen.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adolphs, H.D. und Steffens, L.: Evaluation of the immunocompetence of patients with transitional cell carcinoma of the bladder. Urol. Res. 5/1: 29–33 (1977).

    Article  PubMed  CAS  Google Scholar 

  2. Adolphs, H.D. und Steffens, L.: Correlation between tumor stage, tumour grade, and immunocompetence in patients with carcinoma of the bladder and prostate. Eur. Urol. 3/1: 23–25 (1977).

    PubMed  CAS  Google Scholar 

  3. Albert, L., Arndt, J., Hienzsch, E. und Kriester, A.: Probleme und Ergebnisse der kombinierten Behandlung maligner Harnblasentumoren im höheren Lebensalter. Z. Alternforsch. 32/2: 165–169 (1977).

    CAS  Google Scholar 

  4. Alsabti, E.A.K.: Serum alphafetoprotein in bladder carcinoma. Oncology 34/2: 78–79 (1977).

    Article  PubMed  CAS  Google Scholar 

  5. Alsabti, E.A.K.: Prognostic value of urinary fibrinogen degradation products in bladder carcinoma. Eur. Surg. Res. 11/3: 185–190 (1979).

    Article  PubMed  CAS  Google Scholar 

  6. Berlie, J., Janin, M.L., Hucher, M.: Mortalite par Cancer de la vessie en France. De 1952 a 1976. Son evolution croissante et sa repartition geographique particuliere dans le sud de la France. Cancer (Paris) 66/3: 317–326 (1979).

    CAS  Google Scholar 

  7. Bredael, J.J., Croker, B.P., und Glenn, J.F.: The curability of invasive bladder cancer treated by radical cystectomy. Eur. Urol. 6/4: 206–210 (1980).

    PubMed  CAS  Google Scholar 

  8. Busch, C., Engberg, A., Norlen, B.J. und Stenkvist, B.: Malignancy grading of epithelial bladder tumours. Reproducibility of grading and comparison between forceps biopsy, aspiration biopsy and exfoliative cytology. Scand. J. Urol. Nephrol. 11/2: 143–148 (1977).

    Article  PubMed  CAS  Google Scholar 

  9. Catalona, W.J., Smolev, J.K. und Harty, J.I.: Prognostic value of host immunocompetence in urologic cancer patients. J. Urol. (Baltimore) 114/6: 922–926 (1975).

    CAS  Google Scholar 

  10. Cowen, P.N.: False cytodiagnosis of bladder malignancy due to previous radiotherapy. Brit. J. Urol. 47/4: 405–412 (1975).

    Article  PubMed  CAS  Google Scholar 

  11. Daughtry, J.D., Susan, L.P., Stewart, B.H. und Straffon, R.A.: Ileal conduit and cystectomy: a 10 year retrospective study of ileal conduits performed in conjunction with cystectomy and with a minimum 5 year follow up. J. Urol. 118/4: 556–557 (1977).

    PubMed  CAS  Google Scholar 

  12. Denis, L., Nowe, P. und Declercq, G.: Diagnostic contribution of bladder washing and multiple biopsies in bladder cancers. Eur. Urol. 118/4: 556–557 (1977).

    Google Scholar 

  13. De Voogt, H.J.: Value of urine cytology for early diagnosis of urothelial tumors (Germ). Die Bedeutung der Harnzytologie für die Frühdiagnose von Urotheltumoren. Therapiewoche 29/13: 2242–2245 (1979).

    Google Scholar 

  14. Duckett, J.W. Jr., Cromie, W.B. und Bongiovanni, A.M.: Genitourinary tumors in children. Semin. Oncol. 1/1: 71–75 (1974).

    PubMed  Google Scholar 

  15. Elhilali, M.M., Brosman, S.A., Vescera, C.: The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer. Cancer (Philadelphia) 41/5: 1765–1770 (1978).

    Article  CAS  Google Scholar 

  16. Ellingwood, K.E., Drylie, D.M., De Ture, F.A. und Million, R.R.: Postdiversion precystectomy irradiation for cancer of the bladder. Cancer (Philadelphia) 43/3: 1032–1036 (1979).

    Article  CAS  Google Scholar 

  17. Esposti, P.L., Edsmyr, F. und Tribukait, B.: The role of exfoliative cytology in the management of bladder carcinoma. Urol. Res. 6/4: 197–200 (1978).

    Article  PubMed  CAS  Google Scholar 

  18. Farrow, G.M., Utz, D.C., Rife, C.C. und Greene, L.F.: Clinical observations on sixty nine cases of in situ carcinoma of the urinary bladder. Cancer Res. 37/811; 2794–2798 (1977).

    PubMed  CAS  Google Scholar 

  19. Flanagan, M.J. und Miller, A. III.: Evaluation of bladder washing cytology for bladder cancer surveillance. J. Urol. 119/1: 42–43 (1978).

    PubMed  CAS  Google Scholar 

  20. Fleisher, M., Grabstald, H., Whitmore, W.F. Jr.: The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease. J. Urol. 117/5: 635–637 (1977).

    PubMed  CAS  Google Scholar 

  21. Fraser, R.A., Ravry, M.J., Segura, J.W. und Go, V.L.W.: Clinical evaluation of urinary and serum carcinoembryonic antigen in bladder cancer. J. Urol. (Baltimore) 114/2: 226–229 (1975).

    CAS  Google Scholar 

  22. Freni, S.C., Dalderup, L.M., Oudegeest, J.J. und Wensveen, N.: Erythrocyturia, Smoking and occupation. J. Clin. Path. 30/4: 341–344 (1977).

    Article  PubMed  CAS  Google Scholar 

  23. Genster, H.G., Mommsen, S. und Hojsgaard, A.: Total cystectomy for bladder carcinoma (Germ). Totale Zystektomie bei Blasenkarzinom. Therapiewoche 29/13: 2204–2208 (1979).

    Google Scholar 

  24. Greiner, R., Zaunbauer, W., Skaleric, K. und Veraguth, P.: Lymphknotenmetastasen und Ureterobstruktion als prognostische Parameter der perkutanen Strahlentherapie des Harnblasenkarzinoms. Strahlentherapie 154/9: 617–621 (1978).

    PubMed  CAS  Google Scholar 

  25. Haschek, H. und Studier, G.: Neue Aspekte in der Behandlung des Blasenkarzinoms im Alter Aktuel. Gerontol. 9/2: 53–58 (1979).

    CAS  Google Scholar 

  26. Jacobi, G.H., Jacobi-Hermanns, E. und Altwein, J.E.: Die Prognose des Harnblasenkarzinoms. Georg Thieme Verl. 1979 (Hrsg.).

    Google Scholar 

  27. Jacobi, G.H. und Altwein, J.E.: Divertikeltumoren der Harnblase. Analyse von 17 Beobachtungen. Aktuel. Urol. 8/5: 243–251 (1977).

    Google Scholar 

  28. Jakobsen, A., Bichel, P. und Sell, A.: Flow cytometric investigations of human bladder carcinoma compared to histological classification. Urol. Res. 7/2: 109–112 (1972).

    Google Scholar 

  29. Jakse, G. und Hofstaedter, F.: Further experiences with the specific red cell adherence test (SRCA) in bladder cancer. A histological and cytological study. Eur. Urol. 4/5: 356–360 (1978).

    PubMed  CAS  Google Scholar 

  30. Kruglov, A.N. und Tomashevich, V.V.: 22: 147 (1956).

    Google Scholar 

  31. Lane, V.: Prognosis in carcinoma of the urachus. Eur. Urol. 2/6: 282–283 (1976).

    PubMed  CAS  Google Scholar 

  32. Lange, P.H., Limas, C. und Fraley, E.E.: Tissue bloodgroup antigens and prognosis in low stags transitional cell carcinoma of the bladder. U. Urol. 11/1: 52–55 (1978).

    Google Scholar 

  33. Martinez-Pineiro, J.A., Muntanola, P. und Hidalgo, L.: Immunological evaluation in patients with urological cancers. Eur. Urol. 3/3: 159–162 (1977).

    PubMed  CAS  Google Scholar 

  34. Martinez-Pineiro, J.A., Pertusa, C., Maganto, E.: Urinary fibrinogen degradation products (FDP) in bladder cancer. Eur. Urol. 4/5: 348–350 (1978).

    PubMed  CAS  Google Scholar 

  35. Mauermayer, W., Tauber, R. und Steuer, G.: Epitheliale Harnblasentumoren im Kindesalter und beim Jugendlichen. Urologe Ausg. A 16/5: 286–289 (1977).

    CAS  Google Scholar 

  36. McCarron, J.P. und Marshall, V.F.: The survival of patients with bladder tumors treated by surgery: Comparative results of an old and a recent series. J. Urol. 122/3: 322–324 (1979).

    PubMed  CAS  Google Scholar 

  37. McCarthy, J.P., Gavrell, G.J. und Le Blanc, G.A.: Transitional cell carcinoma of bladder in patients under thirty years of age. Urology 13/5: 487–489 (1979).

    Article  PubMed  CAS  Google Scholar 

  38. Mihatsch, M.J., Rist, M., Romppanen, T., und Rutishauser, F.: Prognostic significance of peritumoural inflammation in invasive urothelial bladder carcinoma. Urol Res. 7/2: 97–102 (1979).

    Article  PubMed  CAS  Google Scholar 

  39. Miller, C.T., Neutel, C.I., Nair, R.C.: Relative imprtance of risk factors in bladder carcinogenesis. J. Chronic Dis. 31/1: 51–56 (1978).

    Article  PubMed  CAS  Google Scholar 

  40. Motomiya, Y., Ohzono, S., Shiomi, T.: Studies on lactic dehydrogenase of patients with urinary bladder tumors. I. Urinary lactic dehydrogenase. Invest. Urol. 17/2: 120–124 (1979).

    PubMed  CAS  Google Scholar 

  41. Motomiya, Y., Yamada, K., Matsushima, S.: Studies on urinary isozymes of lactic dehydrogenase and betaglucuronidase in patients with bladder tumors. Urol. Res. 3/1: 41–48 (1975).

    Article  PubMed  CAS  Google Scholar 

  42. Orandi, A. und Orandi, M.: Urine cytology in the detection of bladder tumor recurrence. J. Urol. (Baltimore) 116/5: 568–569 (1976).

    CAS  Google Scholar 

  43. Orjasaeter, H., Fossa, S.D., Schjolseth, S.A. und Fjaestad, K.: Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra. Cancer (Philadelphia) 42/1: 287–295 (1978).

    Article  CAS  Google Scholar 

  44. Page, B.H., Levison, V.B. und Curwen, M.P.: The site of recurrence of non-infiltrating bladder tumors. Br. J. Urol. 50/4: 237–242 (1978).

    Article  PubMed  CAS  Google Scholar 

  45. Prout, G.R. Jr., Cox, C.E., Cummings, K.B.: Cytology and histopathology fo bladder cancer cases in a prospective longitudinal study. National Bladder Cancer Collaborative Group A. Cancer Res. 37/811; 2911–2915 (1977).

    Google Scholar 

  46. Prout, G.R. Jr., Griffin, P.P. und Shipley, W.U.: Bladder carcinoma as a systemic disease. Cancer (Philadelphia) 43/6: 2532–2539 (1979).

    Article  Google Scholar 

  47. Rehn, L.: Arch. Klin. Chir. 50: 588–600 (1895).

    Google Scholar 

  48. Richie, J.P., Blute, R.D. Jr. und Waisman, J.: Immunologic indicators of prognosis in bladder cancer; The importance of cell suface antigens. U. Urol. 123/1: 22–24 (1980).

    CAS  Google Scholar 

  49. Richie, J.P., Skinner, D.G. und Kaufmann, J.J.: Radical cystectomy for carcinoma of the bladder: 16 years of experience. J. Urol. (Baltimore) 113/2: 186–189 (1975).

    CAS  Google Scholar 

  50. Sandberg, A.A.: Chromosome markers and progression in bladder cancer. Cancer Res. 37/811: 2950–2956 (1977).

    PubMed  CAS  Google Scholar 

  51. Sarma, K.P.: Tumours of the Urinary Bladder. Butterworths, London (Hrsg.) 1969.

    Google Scholar 

  52. Schellhammer, P.F., Bean, M.A. und Whitemore, W.F. Jr.: Prostatic involvement by transitional cell carcinoma: Pathogenesis, patterns and prognosis. J. Urol. 118/3: 399–403 (1977).

    PubMed  CAS  Google Scholar 

  53. Seemayer, T.A., Knaack, J., Thelmo, W.L.: Further observations on carcinoma in situ of the urinary bladder: silent but extensive intraprostatic involvement. Cancer (Philad.) 36/2: 514–520 (1965).

    Article  Google Scholar 

  54. Suprun, H. und Bitterman, W.: A correlative cytohistologie study on the interrelationship between exfoliated urinary bladder carcinoma cell types and the staging and grading of these tumors. Acta Cytol. (Balt.) 19/3: 265–273 (1975).

    CAS  Google Scholar 

  55. Turner, A.G., Carter, S., Higgins, E.: The clinical diagnostic value of the carcinoembryonic antigen (CEA) in haematuria. Brit. J. Urol. 49/1: 61–66 (1977).

    Article  PubMed  CAS  Google Scholar 

  56. Varkarakis, M.J., Gaeta, J., Moore, R.H. und Murphy, G.P.: Prognosis of bladder carcinoma in patients treated with cystectomy. Int. Urol. Nephrol. (Budap.) 7/1: 39–48 (1975).

    Article  CAS  Google Scholar 

  57. Wahren, B., Edsmyr, F. und Zimmerman, R.: Measurement of urinary CEA like substance. An aid in management of patients with bladder carcinoma. Cancer (Philad.) 36/4: 1490–1495 (1975).

    Article  CAS  Google Scholar 

  58. Weaver, P.C., Learmonth, I.D., Thomas, T.L.: Advanced bladder carcinoma treated by cystectomy: A report on twenty-three years experience (with special reference to salvage cystectomy following radical radiotherapy). Clin. Oncol. 5/1: 3–9 (1979).

    PubMed  CAS  Google Scholar 

  59. Williams, G. und Castro, J.E.: The diagnostic and prognostic significance of delayed hypersensitivity skin testing in patients with urological cancer. Brit. J. Urol. 47/1: 97–101 (1975).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Klinik und Poliklinik der Universität, Langenbeckstraße 1, 6500, Mainz, Germany

    Dr. U. Engelmann & G. H. Jacobi

Authors
  1. Dr. U. Engelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. H. Jacobi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Städtische Urologische Klinik, Akademisches Lehrkrankenhaus der Joh.-Wolfg.-Goethe-Univ. Frankfurt/Main, 6100, Darmstadt, Germany

    O. Hallwachs

  2. Urologische Abteilung Bundeswehrkrankenhaus Ulm, Akademisches Krankenhaus der Universität Ulm, Oberer Eselsberg 40, 7900, Ulm, Germany

    J. E. Altwein

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Engelmann, U., Jacobi, G.H. (1982). Prognostische Parameter des Harnblasenkarzinoms. In: Hallwachs, O., Altwein, J.E. (eds) Intravesikale Chemotherapie und transurethrale Verfahren zur Behandlung und Rezidivprophylaxe des Blasenkarzinoms . Fortschritte der Urologie und Nephrologie, vol 19. Steinkopff. https://doi.org/10.1007/978-3-642-72357-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72357-5_2

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0605-3

  • Online ISBN: 978-3-642-72357-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation